Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - colecalciferol, quantity: 175 microgram - capsule, soft - excipient ingredients: soya oil; purified water; patent blue v; gelatin; glycerol; dl-alpha-tocopherol; allura red ac; titanium dioxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400 - for the treatment of vitamin d deficiency in adults and adolescents as directed by your medical practitioner or pharmacist.,for the prevention of vitamin d deficiency in high risk individuals under the supervision of a medical practitioner.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - tramazoline hydrochloride, quantity: 1.184 mg/ml - spray, solution - excipient ingredients: purified water; glycerol; sodium chloride; hypromellose; sodium bicarbonate; magnesium sulfate heptahydrate; magnesium chloride hexahydrate; sodium hydroxide; camphor; cineole; povidone; calcium chloride dihydrate; benzalkonium chloride; menthol; citric acid monohydrate - for the symptomatic relief of nasal congestion associated with common cold, hayfever and rhinitis.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - tramazoline hydrochloride, quantity: 1.18 mg/ml - spray, solution - excipient ingredients: purified water; dibasic sodium phosphate dihydrate; citric acid monohydrate; sorbitol solution (70 per cent) (non-crystallising); sodium chloride; benzalkonium chloride - symptomatic relief of nasal congestion associated with common cold, hayfever and rhinitis.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 1.6 mg/ml - oral liquid - excipient ingredients: menthol; purified water; benzoic acid; sucralose; maltitol solution; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 10 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; acacia; white beeswax; calcium hydrogen phosphate dihydrate; stearic acid; maize starch; macrogol 6000; tartaric acid; purified talc; sucrose; povidone; carnauba wax; titanium dioxide; soluble maize starch - spasm of the gastrointestinal tract

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: benzoic acid; maltitol solution; menthol; purified water; sucralose; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: maltitol solution; hyetellose; benzoic acid; sucralose; purified water; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - calcium pantothenate -